The progesterone-to-metaphase II oocyte ratio (P/MII) combines trigger-day progesterone with mature oocyte count after retrieval. This ratio may reflect ovarian response and embryo allocation during in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles. A retrospective cohort study included 7,778 IVF/ICSI cycle records, utilizing 4,273 positive-transfer records for analysis.
Study Results and Analysis
A retrospective cohort study included 7,778 IVF/ICSI cycle records, utilizing 4,273 positive-transfer records for analysis. Clinical and laboratory data were linked to enable post hoc analyses of extended culture counts, retrieval order, transfer dates, thawing records, and source-identifier grouping. The initial ratio for blastocysts per recorded 2PN zygote was 0.796 with a 95% confidence interval (CI) of 0.762–0.831. Adjusted analyses, using a 2PN denominator, yielded a rate ratio of 0.934 (90.2–96.8), while a culture denominator resulted in a rate ratio of 0.974 (94.5–1.005), with a P value of 0.101. The continuous culture-count association showed a small effect (aRR 0.993 per 0.01, 0.989–0.997). A total of 6,148 cycles involved first retrievals, and 1,630 involved later retrievals. Within first-retrieval, date-consistent records without thawing evidence, the P/MII ratio was associated with clinical pregnancy flags (aOR 0.952, 0.919–0.986; P = 0.006), but the association was uncertain for live birth flags (0.968, 0.935–1.002; P = 0.067). Source-identifier-grouped live birth areas under the receiver operating characteristic curve (AUCs) were 0.623 with the components, 0.623 with P/MII, and 0.624 with all three. The study found that recorded associations depended on the culture population, denominator, and outcome. Incremental clinical usefulness was not established. The data did not support a physiological ratio mechanism or a clinical cutoff for trigger-day or freeze-all decisions.